These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Effects of amantadine on tardive dyskinesia and pseudo-parkinsonism. Janowsky DS; el-Yousef MK; Davis JM; Sekerke HJ; Morris DR; Decker B N Engl J Med; 1972 Apr; 286(14):785. PubMed ID: 4554521 [No Abstract] [Full Text] [Related]
9. [Long-term therapy of parkinsonism using amantadine salts]. Damielczyk W; Struppler A; Velho-Groneberg P; Clemens R; Diehl LW Med Welt; 1976 Apr; 27(14):669-75. PubMed ID: 1263820 [No Abstract] [Full Text] [Related]
10. L-dopa and amantadine for Parkinsonism. Drug Ther Bull; 1970 Aug; 8(17):65-7. PubMed ID: 5480244 [No Abstract] [Full Text] [Related]
11. [Therapeutic association of amantadine and L-Dopa in parkinsonism]. Signorelli CD; D'Andrea F; De Divitiis E; Cerillo A Minerva Med; 1971 Oct; 62(82):4015-6. PubMed ID: 5125068 [No Abstract] [Full Text] [Related]
12. [Electromyographic aspects of laro-dopa therapy]. Càmpeanu E; Mareş V; Dumitru E; Kory S Neurol Psihiatr Neurochir; 1973; 18(6):551-8. PubMed ID: 4790487 [No Abstract] [Full Text] [Related]
13. [Amantadine treatment in parkinsonism]. Holmsen R Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2118-9. PubMed ID: 4773984 [No Abstract] [Full Text] [Related]
14. [Amantadine hydrochloride in patients with parkinsonism in a Geriatric Rehabilitation Center]. Antonini FM; Baroni A Minerva Med; 1971 Oct; 62(82):4027-30. PubMed ID: 5125072 [No Abstract] [Full Text] [Related]
15. [Current treatment of Parkinsonism with amantadine hydrochloride]. Gerstenbrand F; Gründig E; Musiol A Pol Tyg Lek; 1972 Jul; 27(23):878-9. PubMed ID: 5040531 [No Abstract] [Full Text] [Related]
16. [Effects of amantadine therapy on sleep spindles in patients with parkinsonism and comparative analysis of L-dopa effects]. Puca FM; Pigneri MT Boll Soc Ital Biol Sper; 1972 May; 48(9):237-40. PubMed ID: 5070096 [No Abstract] [Full Text] [Related]
17. The treatment of parkinsonism with L-Dopa and amantadine. Green J J Fla Med Assoc; 1970 Jun; 57(6):28-33. PubMed ID: 5445813 [No Abstract] [Full Text] [Related]
18. [Amantadine in the treatment of transitory hypokinesia in patients with parkinsonism during therapy with L-Dopa]. De Divitiis E; D'Andrea F; Signorelli CD; Cerillo A Minerva Med; 1971 Oct; 62(82):4007-8. PubMed ID: 5125065 [No Abstract] [Full Text] [Related]
19. Amantadine hydrochloride in the treatment of Parkinsonism. A controlled trial. Appleton DB; Eadie MJ; Sutherland JM Med J Aust; 1970 Oct; 2(14):626-9. PubMed ID: 4920572 [No Abstract] [Full Text] [Related]
20. The antiparkinson properties of amantadine in drug-induced parkinsonism. Kelly JT; Abuzzahab FS J Clin Pharmacol New Drugs; 1971; 11(3):211-4. PubMed ID: 5211353 [No Abstract] [Full Text] [Related] [Next] [New Search]